153 related articles for article (PubMed ID: 16922414)
1. [HIV-1 and ubiquitination].
Takaori-Kondo A
Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1433-6. PubMed ID: 16922414
[No Abstract] [Full Text] [Related]
2. Virus-host interactions: role of HIV proteins Vif, Tat, and Rev.
Strebel K
AIDS; 2003; 17 Suppl 4():S25-34. PubMed ID: 15080177
[No Abstract] [Full Text] [Related]
3. [How Vif regulates the infectivity of HIV-1].
Takaori-Kondo A
Seikagaku; 2004 Dec; 76(12):1569-73. PubMed ID: 15675371
[No Abstract] [Full Text] [Related]
4. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vif: counteracting innate antiretroviral defenses.
Cullen BR
Mol Ther; 2003 Oct; 8(4):525-7. PubMed ID: 14565218
[No Abstract] [Full Text] [Related]
6. [HIV-1, a very Vif virus].
Schwartz O
Med Sci (Paris); 2004 Feb; 20(2):139-41. PubMed ID: 14997428
[No Abstract] [Full Text] [Related]
7. Lentiviral Vif: viral hijacker of the ubiquitin-proteasome system.
Ehrlich ES; Yu XF
Int J Hematol; 2006 Apr; 83(3):208-12. PubMed ID: 16720549
[TBL] [Abstract][Full Text] [Related]
8. New insights into the role of Vif in HIV-1 replication.
Schröfelbauer B; Yu Q; Landau NR
AIDS Rev; 2004; 6(1):34-9. PubMed ID: 15168739
[TBL] [Abstract][Full Text] [Related]
9. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
Yu X; Yu Y; Liu B; Luo K; Kong W; Mao P; Yu XF
Science; 2003 Nov; 302(5647):1056-60. PubMed ID: 14564014
[TBL] [Abstract][Full Text] [Related]
10. Good to CU.
Gu Y; Sundquist WI
Nature; 2003 Jul; 424(6944):21-2. PubMed ID: 12840737
[No Abstract] [Full Text] [Related]
11. Hypermutation of HIV-1 DNA in the absence of the Vif protein.
Lecossier D; Bouchonnet F; Clavel F; Hance AJ
Science; 2003 May; 300(5622):1112. PubMed ID: 12750511
[No Abstract] [Full Text] [Related]
12. HIV: a tough viral nut to crack.
Pomerantz RJ
Nature; 2002 Aug; 418(6898):594-5. PubMed ID: 12167840
[No Abstract] [Full Text] [Related]
13. HIV-1 Vif: HIV's weapon against the cellular defense factor APOBEC3G.
Kremer M; Schnierle BS
Curr HIV Res; 2005 Oct; 3(4):339-44. PubMed ID: 16250885
[TBL] [Abstract][Full Text] [Related]
14. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.
Zheng YH; Irwin D; Kurosu T; Tokunaga K; Sata T; Peterlin BM
J Virol; 2004 Jun; 78(11):6073-6. PubMed ID: 15141007
[TBL] [Abstract][Full Text] [Related]
15. APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
Franca R; Spadari S; Maga G
Med Sci Monit; 2006 May; 12(5):RA92-8. PubMed ID: 16641889
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant.
Opi S; Kao S; Goila-Gaur R; Khan MA; Miyagi E; Takeuchi H; Strebel K
J Virol; 2007 Aug; 81(15):8236-46. PubMed ID: 17522211
[TBL] [Abstract][Full Text] [Related]
17. The viral infectivity factor (Vif) of HIV-1 unveiled.
Rose KM; Marin M; Kozak SL; Kabat D
Trends Mol Med; 2004 Jun; 10(6):291-7. PubMed ID: 15177194
[TBL] [Abstract][Full Text] [Related]
18. Complementary function of the two catalytic domains of APOBEC3G.
Navarro F; Bollman B; Chen H; König R; Yu Q; Chiles K; Landau NR
Virology; 2005 Mar; 333(2):374-86. PubMed ID: 15721369
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Vif and APOBEC3G: multiple roads to one goal.
Goncalves J; Santa-Marta M
Retrovirology; 2004 Sep; 1():28. PubMed ID: 15383144
[TBL] [Abstract][Full Text] [Related]
20. Recent insights into HIV-1 Vif.
Navarro F; Landau NR
Curr Opin Immunol; 2004 Aug; 16(4):477-82. PubMed ID: 15245742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
